SCOR SE Posts Record Profit and Confident Outlook

SCOR SE (ADR) ((SCRYY)) has held its Q4 earnings call. Read on for the main highlights of the call.

SCOR SE struck an upbeat tone on its latest earnings call, underscoring record profitability, robust capital and disciplined execution of its Forward ’26 plan. Management balanced this optimism with a sober view of competitive pressures, volatile man‑made losses and regulatory uncertainty, but insisted that strong underwriting and capital generation more than offset these headwinds.

Record Net Income Caps a Landmark Year

SCOR reported full‑year 2025 net income of EUR 846 million, the highest in its history, driven by solid contributions from Property & Casualty, Life & Health and investments. Management emphasized that this level of profitability validates its strategic reset and demonstrates the resilience of the diversified business model.

ROE Surges Well Above Long‑Term Targets

Return on equity reached 19.1% for the full year, with Q4 implying an annualized ROE of 21.1%, both comfortably above the group’s target range. Executives highlighted that such returns were achieved without compromising risk discipline, reflecting improved underwriting margins and tight expense control.

Solvency II Ratio at the Top of the Range

The Solvency II ratio rose to 215%, up five points year on year and at the high end of SCOR’s target corridor. Management attributed this to strong net operating capital generation in 2025, giving the group ample flexibility to absorb shocks while continuing to invest and return capital to shareholders.

Economic Value Creation Beats Forward ’26 Ambitions

Economic value increased 13.7% at constant economics, comfortably ahead of the Forward ’26 target of 9% annual growth. Economic value per share stands at roughly EUR 48, broadly stable over the year, underlining that SCOR is growing its franchise without diluting per‑share value.

Dividend Raised and Capital Policy Reaffirmed

The Executive Committee proposed a dividend of EUR 1.90 per share for 2025, a 5.6% increase from EUR 1.80. This payout would become the new floor under SCOR’s ratchet policy, signaling management’s confidence in the sustainability of earnings and capital generation.

Cost Savings Arrive Early, Supporting Efficiency

SCOR achieved EUR 170 million of cost savings in just two years, one year ahead of plan, allowing management expenses to stay flat versus 2023. The group expense ratio was about 7.4% in 2025, consistent with a longer‑term guidance band of 7–8%, reinforcing the focus on structural efficiency.

P&C Underwriting Metrics Remain a Standout

The P&C combined ratio continued to outperform the Forward ’26 target of below 87%, supported by disciplined risk selection. Natural catastrophe losses were well contained, with a Q4 nat‑cat ratio of 7.6% and 6.8% year to date against a 10% annual budget, while the attritional loss ratio improved to 76.4% from 77% the prior year.

Life & Health Delivers Above‑Plan Results

Life & Health posted full‑year new business contractual service margin of EUR 464 million, above the assumed EUR 0.4 billion. The line also generated an insurance service result of EUR 450 million for the year, including EUR 115 million in Q4, beating guidance and underscoring the profitability of recent underwriting.

Investment Income Benefits from Higher Yields

Return on invested assets reached 3.6% in Q4, producing EUR 209 million of investment income and lifting overall earnings. The regular income yield of about 3.8% came from a high‑quality credit portfolio, where expected credit losses remain broadly unchanged, leaving room for steady income going forward.

Balance Sheet and Risk Framework Strengthened

Financial leverage was managed at 25.3%, slightly higher than 24.5% previously after a successful Tier 2 issuance but still within a conservative range. SCOR also raised its risk‑adjustment confidence level to roughly 75.5%–82.5% and continued to enhance asset‑liability management and data capabilities, including several flagship AI projects.

P&C Revenue Softness and SBS Drag

Despite strong margins, P&C insurance revenue slipped 1.6% year on year in Q4 at constant currency, with full‑year adjusted insurance revenue flat. Reinsurance grew around 2%, but the SBS segment declined roughly 4%, reflecting weaker demand or pricing in certain niches and tempering the growth narrative.

More Competitive Pricing Squeezes Margins

Management warned of a more competitive landscape in P&C, particularly in some inward and specialty lines where margins are under pressure. January renewals were handled with underwriting discipline, and SCOR walked away from less attractive business, but the softer market tone could limit future rate‑driven earnings upside.

Addressing Onerous Life Contracts with Reserves

A loss component emerged in Life & Health tied to a small set of underperforming contracts, notably an Israeli runoff portfolio. Cumulative negative adjustments across the year triggered prudential reserve strengthening, which management framed as largely behind them and necessary to clean up legacy exposures.

Seasonality and Volatility in New Business CSM

Q4 P&C new business CSM was modest, reflecting normal seasonality and early recognition of a large proportional retrocession renewal. Life & Health results, though strong for the year, still showed quarterly volatility, reminding investors that earnings may remain lumpy even as the overall trajectory improves.

Refinancing and Capital Structure Timing

Leverage ticked up after new Tier 2 issuance, and SCOR flagged a potential repayment of EUR 283 million, the remaining portion of a legacy Tier 2 instrument with a first call in mid‑2026. The group is weighing refinancing options to keep its capital structure efficient while preserving flexibility amid changing markets.

Regulatory Reform May Trim Solvency Headroom

Pending Solvency II reforms, expected to apply from 2027, could reduce SCOR’s solvency ratio by an estimated 10–15 percentage points. The impact includes the likely loss of contingent capital benefits, and management is monitoring developments closely while stressing that current capital levels give ample buffer.

Man‑Made Losses Add Quarterly Noise

Man‑made losses were heavier in Q4, following an elevated Q3, contributing to quarter‑to‑quarter volatility in P&C earnings. SCOR argued that, on a full‑year basis, man‑made claims remained within normal expectations, suggesting that these events have not derailed the broader underwriting performance.

Arbitration and Tax Structure Adjustments

An ongoing arbitration case remains unresolved, with the panel’s decision expected in 2026 and provisions currently booked as best estimates. The group’s effective tax rate was about 28% for 2025, and management continues structural and tax platform changes, including relocations, while guiding for a roughly 30% tax rate assumption for 2026.

Forward Guidance Anchored in Forward ’26 Targets

Looking ahead, SCOR reiterated confidence in its Forward ’26 plan, including a P&C combined ratio below 87% in 2026 and continued opportunistic buffer building already exceeding the initial EUR 300 million goal. Management targets net operating capital generation of 3–5 percentage points of solvency next year, underpinned by strong Life & Health CSM, solid investment yields, tight expenses and a higher dividend floor.

SCOR’s call painted a picture of a reinsurer firmly back on the front foot, pairing record earnings with strong capital and disciplined underwriting. While competition, regulatory changes and one‑off legal and loss items pose challenges, investors were left with the impression of a franchise capable of delivering attractive returns and growing economic value through the cycle.